Enhancement and Comparison of (Ceftazidime-)Avibactam Plus Aztreonam Susceptibility Tests for Stenotrophomonas maltophilia in Clinical Diagnostics

Curr Microbiol. 2023 Dec 5;81(1):28. doi: 10.1007/s00284-023-03530-7.

Abstract

Stenotrophomonas maltophilia is naturally resistant to many antimicrobials. We evaluated the in vitro activity and reproducibility of two different super-position methods of aztreonam in combination with ceftazidime-avibactam for S. maltophilia and compared these results with the recently available aztreonam-avibactam gradient strip. We recommend an improved super-position method that avoids the possible risk of handling a contaminated aztreonam strip. In addition, we report that the cefazidime-avibactam and aztreonam super-position method showed increased in vitro activity in comparison with aztreonam-avibactam indicating activity of the ceftazidime component in vitro.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Aztreonam* / pharmacology
  • Ceftazidime / pharmacology
  • Microbial Sensitivity Tests
  • Reproducibility of Results
  • Stenotrophomonas maltophilia*
  • beta-Lactamases

Substances

  • Aztreonam
  • Ceftazidime
  • Anti-Bacterial Agents
  • avibactam
  • beta-Lactamases